Lifestyle Interventions for Mild Cognitive Impairment
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how a six-month, online program focused on exercise and nutrition might improve memory and thinking in older adults experiencing cognitive decline. Participants will be divided into four groups, each trying different combinations of exercise, stretching, diet, and education. Known as the LEAD 2.0 Intervention, this program aims to assess the impact of these lifestyle changes. The study seeks individuals aged 65 to 80 who are concerned about their memory or thinking skills and have low physical activity levels and poor diet quality. The goal is to determine if these lifestyle changes can boost cognitive function, physical health, and overall quality of life. All activities and assessments will occur online, so participants need access to a computer or tablet with internet. As an unphased trial, this study offers a unique opportunity to contribute to research that could enhance cognitive health through lifestyle changes.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It might be best to discuss this with the study team or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that regular exercise and a healthy diet can lower the risk of dementia by 30-60% over time. The LEAD 2.0 study examines these benefits through a 6-month online program focused on exercise and nutrition for older adults with mild memory concerns.
This approach relies on lifestyle changes such as exercise and diet, which most people manage well. These changes typically don't cause serious side effects and are associated with improved physical health and mental well-being.
Overall, this program is considered safe because it involves everyday activities like exercising and eating well, which are known to be safe and beneficial for most people.12345Why are researchers excited about this trial?
Researchers are excited about these lifestyle interventions for mild cognitive impairment because they combine exercise, diet, and education in a structured, interactive format, which is distinct from current standard treatments like medication and cognitive training. The approach emphasizes virtual group sessions that foster community support and motivation, potentially enhancing adherence and outcomes. This method provides a holistic, non-pharmaceutical option that may delay cognitive decline by promoting overall brain health through lifestyle changes.
What evidence suggests that this trial's lifestyle interventions could be effective for mild cognitive impairment?
Research has shown that regular exercise and a healthy diet can lower the risk of dementia by 30–60%. For individuals with mild memory problems, starting exercise early can enhance thinking skills. Healthy lifestyle changes, such as staying active and eating well, are linked to better brain health. The LEAD 2.0 study is testing these changes through various treatment arms, including combinations of exercise, diet, and education, delivered online. This approach allows older adults to participate from home. Early signs suggest these lifestyle changes could boost memory and thinking abilities.12346
Who Is on the Research Team?
Laura Middleton, PhD
Principal Investigator
University of Waterloo
Are You a Good Fit for This Trial?
The LEAD 2.0 trial is for adults aged 65-80 in Quebec, Ontario, Manitoba, and Saskatchewan who feel their cognitive abilities are declining but do not have dementia or other severe brain conditions. They should be physically inactive (<75min/week of exercise), have a poor diet, and be able to use a computer with internet for remote participation.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in a 6-month virtual exercise and nutrition intervention
Follow-up
Participants are monitored for changes in cognition, physical function, and quality of life
What Are the Treatments Tested in This Trial?
Interventions
- LEAD 2.0
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Waterloo
Lead Sponsor
Baycrest
Collaborator
University of Ottawa
Collaborator
Université de Montréal
Collaborator